Q: For the purposes of determining a Medicare overpayment, should claims that we are uncertain whether they were appropriate be included? Is this defined under the False Claims Act (FCA)?
This week’s Medicare updates include a new interim final rule on COVID-19 vaccination and payment policies, Part II of the CY 2022 Medicare Advantage and Part D Advance Notice, a proposed rule on DMEPOS coverage policies and fee schedule methodologies, and more!
CMS’ Fourth COVID-19 Interim Final Rule with Comment Period includes additional payment for new COVID-19 treatments, price transparency requirements for COVID-19 diagnostic tests, and coverage for potential vaccines among other provisions.
